NCT00002026已完成不适用
Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)
Glaxo Wellcome2 个研究点 分布在 1 个国家开始时间: 2001年8月31日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 试验地点
- 2
研究概览
简要总结
To evaluate the efficacy of oral acyclovir for the treatment and suppression of Epstein-Barr virus (EBV) related hairy leukoplakia (HL). To determine the long-term safety of acyclovir in the AIDS-related complex (ARC) patient with HL. To monitor the progression of HIV disease in the HL patient and compare to existing historical control data.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Concurrent Medication:
- •Topical antifungal therapy.
- •Patient must have:
- •Newly diagnosed clinical and histological hairy leukoplakia.
- •Positive HIV antibody by licensed ELISA or Western blot.
排除标准
- •Co-existing Condition:
- •Patients with AIDS or a history of intolerance or allergy to acyclovir are excluded.
- •Concurrent Medication:
- •Excluded within 2 weeks of study entry:
- •Systemic antifungal treatment.
- •Excluded within 6 weeks of study entry:
- •Immunomodulators.
- •Systemic antiviral treatment.
- •Patients with AIDS or a history of intolerance or allergy to acyclovir are excluded.
- •Prior Medication:
- •Excluded within 2 weeks of study entry:
- •Systemic antifungal.
- •Excluded within 6 weeks of study entry:
- •Immunomodulators.
- •Systemic antiviral treatment.
- •Excluded within 8 weeks of study entry:
- •Zidovudine (AZT) or other antiretroviral therapy.
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Effects of Long-Term Treatment With Valaciclovir (Valtrex) on Epstein-Barr VirusEpstein Barr Virus InfectionHealthyNCT00005924National Institute of Allergy and Infectious Diseases (NIAID)41
已完成
2 期
Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone TransplantationMultiple Myeloma and Plasma Cell NeoplasmLeukemiaLymphomaNCT00005606Northwestern University
已完成
3 期
Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and MouthHerpes SimplexNCT00004757National Center for Research Resources (NCRR)
已完成
1 期
Controlled Trial of Valacyclovir in Infectious MononucleosisInfectious MononucleosisNCT00274404University of Minnesota20
撤回
不适用
Pilot Study of Antiviral Treatment in Combination With Low-dose Gemcitabine in EBV-associated Gastric Cancer (EBVaGC)Gastric CancerNCT05431244Samsung Medical Center